Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO

被引：0
|
作者：
Marschner, N.
Potthoff, K. [1 ]
Salat, C.
Soeling, U.
Hansen, R.
Grebhardt, S. [1 ]
Horde, J. [1 ]
Nusch, A.
机构：
[1] iOMEDICO AG, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P598
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [21] Efficacy of Nab-Paclitaxel Does Not Seem to Be Associated with SPARC Expression in Metastatic Breast Cancer
    Schneeweiss, Andreas
    Seitz, Julia
    Smetanay, Katharina
    Schuetz, Florian
    Jaeger, Dirk
    Bachinger, Andreas
    Zorn, Markus
    Sinn, Hans-Peter
    Marme, Frederik
    ANTICANCER RESEARCH, 2014, 34 (11) : 6609 - 6615
  • [22] Retrospective Analysis of the Relative Efficacy and Toxicity of Nab-paclitaxel and Docetaxel in Metastatic Breast Cancer
    Howell, S. J.
    Armstrong, A. C.
    Ashcroft, L.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S115 - S116
  • [23] Nab-paclitaxel (Nab-P) in patients with metastatic breast cancer (mBC) with visceral crisis (VC): Efficacy and tolerability.
    Novoselova, Kristina A.
    Vladimirova, Liubov Yu
    Abramova, Natalia A.
    Storozhakova, Anna E.
    Popova, Irina L.
    Tikhanovskaya, Natalia M.
    Ryadinskaya, Ludmila A.
    Lyanova, Aza A.
    Salamov, Georgy
    Teplyakova, Maria
    Prikhodko, Ekaterina
    Tishina, Anna V.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel Discussion
    Jackisch, Christian
    Lueck, Hans-Joachim
    Untch, Michael
    Bischoff, Joachim
    Mueller, Volkmar
    Schmidt, Marcus
    Thill, Marc
    Kiechle, Marion
    BREAST CARE, 2012, 7 (02) : 137 - 143
  • [25] Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy
    Kanazawa, Yoshikazu
    Fujita, Itsuo
    Kakinuma, Diasuke
    Arai, Hiroki
    Matsuno, Kunihiko
    Shimoda, Tomohiro
    Ko, Kazuhide
    Kato, Shunji
    Uchida, Eiji
    ANTICANCER RESEARCH, 2017, 37 (05) : 2715 - 2720
  • [26] AVANTI: A non-interventional study examining the combination of bevacizumab with paclitaxel or capecitabine in metastatic breast cancer
    Schneeweiss, A.
    Fett, W.
    Aktas, B.
    Fruehauf, S.
    Grafe, A.
    Jakob, A.
    Foerster, F.
    Mueller, V.
    CANCER RESEARCH, 2013, 73
  • [27] Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer
    Matsui, Yohei
    Yamada, Tadaaki
    Morimoto, Kenji
    Katayama, Yuki
    Hiranuma, Osamu
    Shiotsu, Shinsuke
    Tamiya, Nobuyo
    Takeda, Takayuki
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    ANTICANCER RESEARCH, 2022, 42 (10) : 4921 - 4928
  • [28] Safety and efficacy of the treatment with Nab-paclitaxel in mEtastaticbREast cancer In elDerlypatiEnts: NEREIDE Study
    Adamo, V.
    Ricciardi, G.
    Schifano, S.
    Russo, A.
    Gebbia, V.
    Blasi, L.
    Giuffrida, D.
    Scandurra, G.
    Savarino, A.
    Butera, A.
    Borsellino, N.
    Verderame, F.
    Caruso, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S114 - S115
  • [29] Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy
    Henderson, I. Craig
    Bhatia, Vinono
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (07) : 919 - 943
  • [30] Real-world efficacy and safety outcomes of nab-paclitaxel (nab-P) in patients (pts) with metastatic breast cancer (MBC): Results from a US health insurance database
    Patt, Debra A.
    Liang, Caihua
    Li, Ling
    Ko, Amy
    Fraser, Cindy Duval
    Corzo, Deyanira
    Enger, Cheryl
    CANCER RESEARCH, 2015, 75
12345